You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MPH

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

ADHD, ADHD, ADHD - Combined Type Trial (CTx-1301 -Dexmethylphenidate 18.75mg, CTx-1301 -Dexmethylphenidate 25mg, CTx-1301

Not yet recruiting
  • ADHD
  • +5 more
  • CTx-1301 -Dexmethylphenidate 18.75mg
  • +3 more
  • (no location specified)
Nov 1, 2022

Chronic GVHD, Chronic Graft-Versus-Host-Disease, Bronchiolitis Obliterans Syndrome Trial run by the National Cancer Institute

Recruiting
  • Chronic Graft vs Host Disease
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 18, 2022

Attention Deficit/Hyperactivity Disorder Trial (Serdexmethylphenidate (SDX) and dexmethylphenidate (d-MPH), )

Not yet recruiting
  • Attention Deficit/Hyperactivity Disorder
  • Serdexmethylphenidate (SDX) and dexmethylphenidate (d-MPH)
  • placebo
  • (no location specified)
Jan 5, 2023

Postoperative Sepsis Trial in Spain (microporous polysaccharide hemospheres (MPH) agent in rectal surgery)

Recruiting
  • Postoperative Sepsis
  • microporous polysaccharide hemospheres (MPH) agent in rectal surgery
  • Elche, Alicante, Spain
  • +4 more
Dec 28, 2021

ADHD Trial in Netanya (MPH)

Recruiting
  • ADHD
  • MPH
  • Netanya, Israel
    Sharon Tsuk
Jun 18, 2022

ADHD Trial in Cincinnati, Seattle (OROS-Methylphenidate (MPH))

Completed
Has Results
  • ADHD
  • OROS-Methylphenidate (MPH)
  • Cincinnati, Ohio
  • +1 more
Jan 7, 2022

Neural Mechanisms of Remission in Children With ADHD

Enrolling by invitation
  • ADHD
  • (no location specified)
Jan 28, 2022

Attention Deficit/Hyperactivity Disorder Trial (Serdexmethylphenidate (SDX) and dexmethylphenidate (d-MPH))

Not yet recruiting
  • Attention Deficit/Hyperactivity Disorder
  • Serdexmethylphenidate (SDX) and dexmethylphenidate (d-MPH)
  • (no location specified)
Feb 9, 2023

Covid19 Trial in Birmingham (Alvelestat, Placebo)

Completed
Has Results
  • Covid19
  • Birmingham, Alabama
    UAB Lung Health Center
Dec 21, 2022

IMAS Optimization and Applicability in an Acute Stroke Setting.

Recruiting
  • Acute Stroke
    • Chicago, Illinois
    • +1 more
    Jul 19, 2022

    Attention Deficit Disorder With Hyperactivity, Diabetes, Type 1 Trial (parental training in behavior management,

    Not yet recruiting
    • Attention Deficit Disorder With Hyperactivity
    • Diabetes Mellitus, Type 1
    • parental training in behavior management
    • +2 more
    • (no location specified)
    Jul 19, 2023

    Brain Injury Traumatic Severe (Diagnosis), Coma, Consciousness, Level Altered Trial in Boston (Methylphenidate)

    Recruiting
    • Brain Injury Traumatic Severe (Diagnosis)
    • +3 more
    • Boston, Massachusetts
      Massachusetts General Hospital
    Feb 1, 2022

    ADHD, ADHD Trial in United States (Methylphenidate)

    Recruiting
    • ADHD
    • Attention Deficit Hyperactivity Disorder
    • Gainesville, Florida
    • +3 more
    Apr 5, 2022

    ADHD, ADHD Trial in New York (Methylphenidate, Atomoxetine)

    Recruiting
    • ADHD
    • Attention Deficit Hyperactivity Disorder
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Apr 5, 2022

    Solid Tumor, Adult, Advanced Solid Tumor, Metastatic Solid Tumor Trial in United Kingdom, United States (Etigilimab dosing,

    Recruiting
    • Solid Tumor, Adult
    • +2 more
    • Phoenix, Arizona
    • +15 more
    Jun 6, 2022

    ADHD Trial in Roma (Methylphenidate, anodal tDCS, sham tDCS)

    Active, not recruiting
    • Attention Deficit Hyperactivity Disorder
    • Roma, Italy
      Bambino Gesù Hospital and Research Institute
    Jul 26, 2022

    Moderate to High-risk Noncardiac Surgery Trial in United States (AcumenTM HPI Software Feature, Non-protocolized Standard of

    Terminated
    • Moderate to High-risk Noncardiac Surgery
    • AcumenTM HPI Software Feature
    • Non-protocolized Standard of Care
    • Sacramento, California
    • +10 more
    Jan 31, 2023

    Sedentary Behavior, Affect, Metabolic Disturbance Trial in Los Angeles (SIT+WALK, EX)

    Recruiting
    • Sedentary Behavior
    • +3 more
    • SIT+WALK
    • EX
    • Los Angeles, California
      Britni Ryan Belcher, PhD, MPH
    Mar 15, 2022

    Metabolic Syndrome Trial in Bergen, Ålesund (MPH_active, MPH_)

    Completed
    • Metabolic Syndrome
    • MPH_active
    • MPH_placebo
    • Bergen, Norway
    • +1 more
    Dec 21, 2020

    ADHD Trial in United States (HLD200 methylphenidate HCl (MPH) Capsules, Placebo)

    Completed
    Has Results
    • Attention Deficit Hyperactivity Disorder
    • HLD200 methylphenidate hydrochloride (MPH) Capsules
    • Placebo
    • Newport Beach, California
    • +6 more
    Jul 1, 2021

    Alpha-1 Antitrypsin Deficiency (AATD), Pi*ZZ, Pi*SZ, Pi*Null, Another Rare Phenotype/Genotype Known to be Associated With Either

    Recruiting
    • Alpha-1 Antitrypsin Deficiency (AATD)
    • +2 more
    • Alvelestat (MPH966)
    • Placebo
    • Birmingham, Alabama
    • +8 more
    Aug 31, 2021

    Perfusion; Complications, Wound; Foot Trial in Dallas (Avazzia Tennant Biomodulator® PRO)

    Terminated
    • Perfusion; Complications
    • Wound; Foot
    • Avazzia Tennant Biomodulator® PRO
    • Dallas, Texas
      University of Texas Southwestern Medical Center, Department of P
    Aug 25, 2021

    Depression Mild, Resilience, Psychological, Adolescent Behavior Trial in Chapel Hill (MFY, HLG)

    Completed
    Has Results
    • Depression Mild
    • +2 more
    • MFY
    • HLG
    • Chapel Hill, North Carolina
      Christine Lathren, MD, MPH
    Apr 26, 2021

    HIV, Risk Reduction, Risk Behavior Trial in Rio de Janeiro, Rio De Janeiro (HIV testing)

    Completed
    • HIV Infections
    • +6 more
    • HIV testing
    • Rio de Janeiro, RJ, Brazil
    • +1 more
    Jan 5, 2023

    Lactose Intolerance Trial in Belton (Lactobacillus acidophilus MPH734, Placebo)

    Recruiting
    • Lactose Intolerance
    • Lactobacillus acidophilus MPH734
    • Placebo
    • Belton, Texas
      University of Mary Hardin-Baylor
    Nov 10, 2020